EICHOR
● Active Not Recruiting
A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy
Condition: Cystic Fibrosis · Sponsor: Vertex Pharmaceuticals Incorporated
About this study
The purpose of this study is to evaluate the long-term safety, tolerability, and efficacy of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in participants with cystic fibrosis.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (195)
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| Banner University of Arizona Medical Center | Tucson, Arizona, United States | — |
| University of Arkansas for Medical Sciences | Little Rock, Arkansas, United States | — |
| Miller Children's Hospital / Long Beach Memorial | Long Beach, California, United States | — |
| Children's Hospital Los Angeles | Los Angeles, California, United States | — |
| Kaiser Permanente | Oakland, California, United States | — |
| University of California Davis Medical Center | Sacramento, California, United States | — |
| University of California San Francisco, Lung Transplant Program | San Francisco, California, United States | — |
| Children's Hospital of Colorado | Aurora, Colorado, United States | — |
| National Jewish Health | Denver, Colorado, United States | — |
| University of Florida, Shands Hospital | Gainesville, Florida, United States | — |
| Joe DiMaggio Cystic Fibrosis & Pulmonary Center | Hollywood, Florida, United States | — |
+ 183 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05444257